Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare AgfiledCriticalBayer Healthcare Ag
Priority to CU20060130ApriorityCriticalpatent/CU20060130A7/en
Publication of CU20060130A7publicationCriticalpatent/CU20060130A7/en
El objeto de la presente invención es una preparación efervescente que contiene una sal efervescente, al menos una sustancia básica farmacéuticamente activa y opcionalmente uno o más principios activos adicionales, caracterizada porque evita la alcalinización de la orina y con ello una acumulación aumentada de la sustancia básica farmacéuticamente activa, un fármaco que contiene esta preparación efervescente, procedimientos para su preparación y su uso.The object of the present invention is an effervescent preparation containing an effervescent salt, at least one pharmaceutically active basic substance and optionally one or more additional active ingredients, characterized in that it prevents the alkalization of the urine and thereby an increased accumulation of the basic substance pharmaceutically active, a drug that contains this effervescent preparation, procedures for its preparation and its use.
CU20060130A2006-06-192006-06-19
EFFECTIVE PREPARATION OF A PHARMACEUTICALLY ACTIVE BASIC SUBSTANCE
CU20060130A7
(en)
COMPOUNDS DERIVED FROM HETEROCICLES REPLACED WITH MORFOLINA, INHIBITORS OF THE PI3 QUINASA ACTIVITY; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; PHARMACEUTICAL KIT; AND ITS USE FOR CANCER PROFILACTIC OR THERAPEUTIC TREATMENT.
COMPOUNDS DERIVED FROM NITROGEN HETEROCICLES; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF PROLIFERATIVE DISEASES.
5-AMINO-3- MALEATE SALT (2 ', 3'-DI-O-ACETYL-BETA-D-RIBOFURANOSIL) -3H-TIAZOLO [4,5-D] PIRIMIDIN-2-ONA; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF A PO INFECTION
COMPOUNDS DERIVED FROM HETEROCICLES REPLACED WITH MORFOLINA, INHIBITORS OF THE ACTIVITY OF PI3 QUINASA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; PHARMACEUTICAL KIT; AND ITS USE IN THE CANCER PROFILACTIC OR THERAPEUTIC TREATMENT
Compounds derived from pyrazolic heterobicycles, inhibitors of thyroxine kinase protein activity; pharmaceutical composition comprising said compounds; and use of the compounds in the treatment of a hyperproliferative disease.
agent for the prophylaxis or treatment of diabetes, insulin sensitizer, compound, prodrug, pharmaceutical agent, and use of the compound or a salt thereof or a prodrug thereof
Compounds derived from pyrimidin-2-yl-1h-indole, atr protein kinase inhibitors; pharmaceutical composition comprising one of the compounds; and use of the compounds in the preparation of useful medicines for the treatment of cancer.
USE OF A COMPOUND THAT ALTERS THE INTERLEUQUINE 1 (IL-1) RECEIVER FOR THE TREATMENT OF ILLNESSES OR OPHTHALMIC DISORDERS; AND PHARMACEUTICAL COMPOSITION UNDERSTANDING THE IL-1 COMPOUND.
PHARMACEUTICAL COMPOSITION THAT INCLUDES 2- [6- (3-AMINO-PIPERIDIN-1-IL) -3-METIL-2,4-DIOXO-3,4-DIHIDRO-2H-PIRIMIDIN-1-ILMETIL] -4-FLUORO- BENZONITRILE; AND USE FOR THE TREATMENT OF DIABETES.
COMPOUNDS DERIVED FROM BIARIL ETER UREA; PHARMACEUTICAL COMPOSITION CONTAINING THEM; AND ITS USE FOR THE TREATMENT OF DISEASES OR AFFECTIONS ASSOCIATED WITH THE AMIDA HIDROLASA ACTIVITY OF FATTY ACIDS (FAAH).
COMPOUNDS DERIVED FROM PIRIMIDO [5,4-D] [2] BENZAZEPINA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF CANCER.
COMPOUNDS DERIVED FROM PIRAZOLO-QUINAZOLINA SUBSTITUTED, MODULATORS OF THE ACTIVITY OF PROTEIN KINASES; PREPARATION PROCESS; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OF CANCER.
COMPOUNDS DERIVED FROM N-SUBSTITUTED GLYCINE, INHIBITORS OF HIF PROLIL HYDROXYLASES; YOUR PREPARATION PROCESS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE IN THE TREATMENT OF THE ANEMIA.
Compounds derived from 2,4-dianilinopyrimidines, protein kinase inhibitors; preparation procedure; pharmaceutical composition; and use for the treatment or prevention of inflammatory diseases, diabetes, and cancer.